Orthofix Medical/$OFIX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Orthofix Medical

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

Ticker

$OFIX
Sector
Primary listing

Employees

1,616

Orthofix Medical Metrics

BasicAdvanced
$560M
-
-$3.18
0.89
-

What the Analysts think about Orthofix Medical

Analyst ratings (Buy, Hold, Sell) for Orthofix Medical stock.

Bulls say / Bears say

Pro forma net sales were up 4% year-over-year on a constant currency basis to $200.7 million in Q2 2025, showing consistent revenue strength despite macroeconomic uncertainty.
U.S. Orthopedics net sales jumped 28% year-over-year in Q2 2025, indicating strong commercial performance and growing market share in U.S. orthopedics.
The company posted positive free cash flow of $4.5 million in Q2 2025—a strong improvement from a $107.8 million negative free cash flow for full-year 2023, highlighting better working capital management and operational control.
Continued operating loss of $16.0 million in Q2 2025 shows the business is still not profitable at its core.
Ending the M6® artificial disc product lines cut Q2 net sales by $2.5 million and is expected to bring around $10 million in related costs in 2025, creating financial pressure in the near term.
High SG&A expenses of $136.5 million used up nearly 98% of gross profit for Q2 2025, leaving little room for the company to turn revenue growth into sustainable operating profits.
Data summarised monthly by Lightyear AI. Last updated on 2 Oct 2025.

Orthofix Medical Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Orthofix Medical Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $OFIX

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs